Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 2Breast 2Thoracic 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 9Breast Neoplasms 6Ovarian Neoplasms 5Prostatic Neoplasms 3Papillomavirus Infections 3Endometrial Neoplasms 3Triple Negative Breast Neoplasms 2Genital Neoplasms, Female 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Site 1Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1Gynecologic Cancer 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Disease 1Colonic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 17Carboplatin 10Paclitaxel 7Trastuzumab 5Nivolumab 5Gemcitabine 5Early Intervention, Educational 5Cyclophosphamide 5Cisplatin 5fludarabine 4cemiplimab 4Psychiatric Rehabilitation 4Fluorouracil 4Docetaxel 4Counseling 4Albumin-Bound Paclitaxel 4tisotumab vedotin 3belinostat 3Radiotherapy 3Polymerase Chain Reaction 3Methods 3Magnetic Resonance Spectroscopy 3Gene Expression Profiling 3Fluorodeoxyglucose F18 3Biopsy 3zimberelimab 2ulixertinib 2pertuzumab 2palbociclib 2osimertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Educational Status × Gynecologic × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡